TPI
PCRX icon

Trust Point Inc’s Pacira BioSciences PCRX Stock Holding History

Trust Point Inc’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,415
Closed -$298K – 528
2024
Q2 		$298K Sell
10,415
-73
-0.7% -$2.08K 0.02% 380
2024
Q1 		$306K Buy
10,488
+3,224
+44% +$99K 0.02% 404
2023
Q4 		$245K Buy
+7,264
New +$213K 0.02% 440

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Trust Point Inc's PCRX Position: Q3 2024 in Review

Trust Point Inc sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 10,415 shares — an estimated $298K sold.

Trust Point Inc first reported a position in PCRX in Q4 2023 and held it in 3 quarters. The position peaked at $306K in Q1 2024. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Trust Point Inc reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Trust Point Inc sold 10,415 Pacira BioSciences shares in Q3 2024, an estimated $298K.
  • Trust Point Inc first reported a position in Pacira BioSciences in Q4 2023 and held it in 3 quarters.
  • Trust Point Inc's Pacira BioSciences position peaked at $306K in Q1 2024.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Trust Point Inc's 13F filing for Q3 2024, filed 17 Oct 2024.